Early Amniotic Membrane Transplantation in Bacterial Keratitis
This trial is active, not recruiting.
|Condition||keratitis of both eyes|
|Sponsor||Farabi Eye Hospital|
|Start date||January 2014|
|End date||April 2016|
|Trial size||14 participants|
|Trial identifier||NCT02716883, 23345|
In this study Investigators are going to do early amniotic membrane transplantation (AMT) for bacterial keratitis.
|Endpoint classification||safety/efficacy study|
|Intervention model||parallel assignment|
|Masking||double blind (subject, caregiver, investigator)|
Time to scar formation
time frame: It needs at most 3 months
Male or female participants of any age.
Inclusion Criteria: Bacterial keratitis being in the first week of diagnosis medically undergoing treatment Exclusion Criteria: thinning limbal extension intraocular extension underlying disease Nocardia keratitis
|Official title||Early Amniotic Membrane Transplantation in Bacterial Keratitis|
|Description||In this study investigators are going to do amniotic membrane transplantation (AMT), early in the first week for bacterial keratitis. Investigators are comparing this technique with no amniotic membrane transplantation (NAMT) in a clinical trial, Inform consent is going to be taken, then the enrolment population is added in the study. Investigators are going to compare the final scar size, the time to scar formation, perforation rate , early need to penetrating keratoplasty (PKP), risk of vision loss (being no light perception (NLP) between two groups.This trial has been approved by the review board in Tehran University of Medical Sciences.( 487/5671)|
Call for more information